Alnylam's lead product, Onpattro (patisiran), is an RNAi therapeutic approved for the treatment of hereditary transthyretin amyloidosis (hATTR), a rare and debilitating genetic disorder. Onpattro has demonstrated significant clinical benefits in patients with hATTR, including improvements in quality of life, ambulation, and cardiac function. Alnylam is also developing a pipeline of promising new RNAi therapeutics for a variety of other diseases, including liver diseases, cardiovascular diseases, and central nervous system (CNS) disorders.
Download the high-quality Alnylam Pharmaceutical Logo Vector for free in various formats, including SVG, PNG, JPG, AI, EPS. This 100% vector-based logo, crafted using Adobe Illustrator, ensures scalability without compromising quality. With a resolution of up to 300 dpi and CMYK color support, the logo is fully layered for effortless editing.
By downloading Alnylam Pharmaceutical Logo Vector you agree with intellectual property rights in our Privacy Policy.
